Livzon Pharmaceutical Group Inc. (1513.HK)
HKD 25.7
(-0.77%)
HKD 25.7
(-0.77%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.24 Billion CNY | -6.74% |
| 2022 | 5.93 Billion CNY | 5.53% |
| 2021 | 5.62 Billion CNY | 24.08% |
| 2020 | 4.53 Billion CNY | 2.81% |
| 2019 | 4.4 Billion CNY | 0.27% |
| 2018 | 4.39 Billion CNY | 3.77% |
| 2017 | 4.23 Billion CNY | 8.2% |
| 2016 | 3.91 Billion CNY | 21.26% |
| 2015 | 3.22 Billion CNY | 17.76% |
| 2014 | 2.74 Billion CNY | 18.88% |
| 2013 | 2.3 Billion CNY | 24.87% |
| 2012 | 1.84 Billion CNY | 41.09% |
| 2011 | 1.3 Billion CNY | 41.88% |
| 2010 | 922.79 Million CNY | 17.0% |
| 2009 | 788.7 Million CNY | 36.1% |
| 2008 | 579.5 Million CNY | 25.02% |
| 2007 | 463.54 Million CNY | -15.22% |
| 2006 | 546.77 Million CNY | -7.01% |
| 2005 | 588.01 Million CNY | -7.13% |
| 2004 | 633.15 Million CNY | -16.22% |
| 2003 | 755.7 Million CNY | 32.07% |
| 2002 | 572.18 Million CNY | 4.66% |
| 2001 | 546.69 Million CNY | 14.5% |
| 2000 | 477.44 Million CNY | -6.64% |
| 1999 | 511.4 Million CNY | 67.1% |
| 1998 | 306.05 Million CNY | 24.25% |
| 1997 | 246.31 Million CNY | 35.7% |
| 1996 | 181.51 Million CNY | 30.38% |
| 1995 | 139.22 Million CNY | 63.23% |
| 1994 | 85.28 Million CNY | 0.0% |
| 1992 | 52.29 Million CNY | 26.71% |
| 1991 | 41.27 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 1.31 Billion CNY | 4.77% |
| 2024 Q2 | 1.26 Billion CNY | -3.61% |
| 2024 Q3 | 1.1 Billion CNY | -10.58% |
| 2023 Q3 | 1.41 Billion CNY | -1.5% |
| 2023 Q1 | 1.42 Billion CNY | -5.34% |
| 2023 FY | 5.53 Billion CNY | -6.74% |
| 2023 Q2 | 1.44 Billion CNY | 1.2% |
| 2023 Q4 | 1.25 Billion CNY | -11.84% |
| 2022 Q1 | 1.57 Billion CNY | 21.52% |
| 2022 Q3 | 1.63 Billion CNY | 33.95% |
| 2022 Q4 | 1.5 Billion CNY | -7.87% |
| 2022 Q2 | 1.21 Billion CNY | -22.84% |
| 2022 FY | 5.93 Billion CNY | 5.53% |
| 2021 Q1 | 1.5 Billion CNY | 19.32% |
| 2021 Q2 | 1.29 Billion CNY | -14.09% |
| 2021 Q3 | 1.52 Billion CNY | 18.19% |
| 2021 Q4 | 1.29 Billion CNY | -14.91% |
| 2021 FY | 5.62 Billion CNY | 24.08% |
| 2020 Q3 | 1.3 Billion CNY | 45.37% |
| 2020 FY | 4.53 Billion CNY | 2.81% |
| 2020 Q1 | 1.07 Billion CNY | 14.54% |
| 2020 Q2 | 895.89 Million CNY | -16.5% |
| 2020 Q4 | 1.26 Billion CNY | -3.21% |
| 2019 Q1 | 1.22 Billion CNY | 12.38% |
| 2019 FY | 4.4 Billion CNY | 0.27% |
| 2019 Q2 | 1.13 Billion CNY | -7.51% |
| 2019 Q3 | 1.1 Billion CNY | -2.43% |
| 2019 Q4 | 936.74 Million CNY | -15.45% |
| 2018 Q1 | 1.15 Billion CNY | 25.71% |
| 2018 Q4 | 1.09 Billion CNY | -1.06% |
| 2018 Q3 | 1.1 Billion CNY | 5.4% |
| 2018 FY | 4.39 Billion CNY | 3.77% |
| 2018 Q2 | 1.04 Billion CNY | -9.02% |
| 2017 Q4 | 916.02 Million CNY | -22.43% |
| 2017 Q2 | 1.06 Billion CNY | -0.75% |
| 2017 Q3 | 1.18 Billion CNY | 10.81% |
| 2017 Q1 | 1.07 Billion CNY | 5.08% |
| 2017 FY | 4.23 Billion CNY | 8.2% |
| 2016 Q4 | 1.02 Billion CNY | 0.8% |
| 2016 FY | 3.91 Billion CNY | 21.26% |
| 2016 Q3 | 1.01 Billion CNY | 0.48% |
| 2016 Q2 | 1 Billion CNY | 15.86% |
| 2016 Q1 | 870.83 Million CNY | 2.52% |
| 2015 Q2 | 734.44 Million CNY | -1.99% |
| 2015 Q4 | 849.46 Million CNY | -5.17% |
| 2015 Q3 | 895.75 Million CNY | 21.96% |
| 2015 Q1 | 749.32 Million CNY | 0.8% |
| 2015 FY | 3.22 Billion CNY | 17.76% |
| 2014 FY | 2.74 Billion CNY | 18.88% |
| 2014 Q4 | 743.38 Million CNY | -1.41% |
| 2014 Q3 | 754.03 Million CNY | 10.94% |
| 2014 Q2 | 679.65 Million CNY | 20.32% |
| 2014 Q1 | 564.86 Million CNY | -18.65% |
| 2013 Q4 | 694.34 Million CNY | 21.67% |
| 2013 Q1 | 495.92 Million CNY | -1.67% |
| 2013 Q3 | 570.7 Million CNY | 4.6% |
| 2013 FY | 2.3 Billion CNY | 24.87% |
| 2013 Q2 | 545.58 Million CNY | 10.02% |
| 2012 Q3 | 486.96 Million CNY | 8.06% |
| 2012 Q1 | 405.27 Million CNY | -3.13% |
| 2012 FY | 1.84 Billion CNY | 41.09% |
| 2012 Q2 | 450.65 Million CNY | 11.2% |
| 2012 Q4 | 504.32 Million CNY | 3.57% |
| 2011 FY | 1.3 Billion CNY | 41.88% |
| 2011 Q1 | 240.63 Million CNY | -18.13% |
| 2011 Q2 | 291.16 Million CNY | 21.0% |
| 2011 Q3 | 359.08 Million CNY | 23.33% |
| 2011 Q4 | 418.35 Million CNY | 16.5% |
| 2010 Q3 | 241.43 Million CNY | 16.82% |
| 2010 FY | 922.79 Million CNY | 17.0% |
| 2010 Q1 | 180.74 Million CNY | -11.94% |
| 2010 Q2 | 206.66 Million CNY | 14.34% |
| 2010 Q4 | 293.94 Million CNY | 21.75% |
| 2009 Q4 | 205.25 Million CNY | -1.61% |
| 2009 FY | 788.7 Million CNY | 36.1% |
| 2009 Q3 | 208.6 Million CNY | -2.03% |
| 2009 Q2 | 212.92 Million CNY | 31.5% |
| 2009 Q1 | 161.92 Million CNY | 1.63% |
| 2008 Q3 | 149.59 Million CNY | -0.03% |
| 2008 Q2 | 149.64 Million CNY | 23.74% |
| 2008 Q1 | 120.94 Million CNY | -15.14% |
| 2008 FY | 579.5 Million CNY | 25.02% |
| 2008 Q4 | 159.32 Million CNY | 6.5% |
| 2007 Q1 | 100.43 Million CNY | -33.47% |
| 2007 Q4 | 142.51 Million CNY | 23.9% |
| 2007 Q3 | 115.02 Million CNY | 8.96% |
| 2007 Q2 | 105.56 Million CNY | 5.11% |
| 2007 FY | 463.54 Million CNY | -15.22% |
| 2006 Q4 | 150.97 Million CNY | 16.66% |
| 2006 Q3 | 129.4 Million CNY | -0.3% |
| 2006 Q2 | 129.8 Million CNY | -4.98% |
| 2006 Q1 | 136.6 Million CNY | -10.62% |
| 2006 FY | 546.77 Million CNY | -7.01% |
| 2005 FY | 588.01 Million CNY | -7.13% |
| 2005 Q4 | 152.83 Million CNY | 3.92% |
| 2005 Q3 | 147.06 Million CNY | 0.68% |
| 2005 Q2 | 146.07 Million CNY | 2.84% |
| 2005 Q1 | 142.03 Million CNY | -11.75% |
| 2004 Q4 | 160.94 Million CNY | 6.43% |
| 2004 FY | 633.15 Million CNY | -16.22% |
| 2004 Q1 | 160.1 Million CNY | 0.71% |
| 2004 Q2 | 160.88 Million CNY | 0.49% |
| 2004 Q3 | 151.22 Million CNY | -6.01% |
| 2003 Q3 | 192.51 Million CNY | -15.28% |
| 2003 Q4 | 158.96 Million CNY | -17.43% |
| 2003 FY | 755.7 Million CNY | 32.07% |
| 2003 Q1 | 188.79 Million CNY | 7.91% |
| 2003 Q2 | 227.23 Million CNY | 20.36% |
| 2002 Q3 | 142.41 Million CNY | -5.86% |
| 2002 Q2 | 151.27 Million CNY | 46.09% |
| 2002 FY | 572.18 Million CNY | 4.66% |
| 2002 Q1 | 103.54 Million CNY | 0.0% |
| 2002 Q4 | 174.95 Million CNY | 22.85% |
| 2001 FY | 546.69 Million CNY | 14.5% |
| 2000 FY | 477.44 Million CNY | -6.64% |
| 1999 FY | 511.4 Million CNY | 67.1% |
| 1998 FY | 306.05 Million CNY | 24.25% |
| 1997 FY | 246.31 Million CNY | 35.7% |
| 1996 FY | 181.51 Million CNY | 30.38% |
| 1995 FY | 139.22 Million CNY | 63.23% |
| 1994 FY | 85.28 Million CNY | 0.0% |
| 1992 FY | 52.29 Million CNY | 26.71% |
| 1991 FY | 41.27 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 24.42 Million HKD | -21364.613% |
| Grand Pharmaceutical Group Limited | 3.86 Billion HKD | -35.793% |
| Extrawell Pharmaceutical Holdings Limited | 35.52 Million HKD | -14656.431% |
| Wai Yuen Tong Medicine Holdings Limited | 353.93 Million HKD | -1381.217% |
| Qianhai Health Holdings Limited | 17.1 Million HKD | -30554.41% |
| Lee's Pharmaceutical Holdings Limited | 590.99 Million HKD | -787.071% |
| Essex Bio-Technology Limited | 1.22 Billion HKD | -326.58% |
| Tongfang Kontafarma Holdings Limited | 503.46 Million HKD | -941.291% |
| PuraPharm Corporation Limited | 216.62 Million HKD | -2320.044% |
| SSY Group Limited | 1.98 Billion HKD | -164.675% |
| JBM (Healthcare) Limited | 163.87 Million HKD | -3099.076% |
| Jacobson Pharma Corporation Limited | 287.34 Million HKD | -1724.442% |
| China Resources Pharmaceutical Group Limited | 29.35 Billion HKD | 82.141% |